MY148252A - 6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines - Google Patents

6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines

Info

Publication number
MY148252A
MY148252A MYPI20041687A MYPI20041687A MY148252A MY 148252 A MY148252 A MY 148252A MY PI20041687 A MYPI20041687 A MY PI20041687A MY PI20041687 A MYPI20041687 A MY PI20041687A MY 148252 A MY148252 A MY 148252A
Authority
MY
Malaysia
Prior art keywords
alkylmethyl
cyclymethyl
substituted pyrazolopyrimidines
pyrazolopyrimidines
substituted
Prior art date
Application number
MYPI20041687A
Other languages
English (en)
Inventor
Martin Dr Hendrix
Lars Dr Barfacker
Christina Dr Erb
Frank-Thorsten Dr Hafner
Heike Dr Heckroth
Dagmar Schaus
Adrian Dr Tersteegen
Franz-Jozef Van Der Dr Staay
Marja Van Dr Kampen
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MY148252A publication Critical patent/MY148252A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
MYPI20041687A 2003-05-09 2004-05-07 6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines MY148252A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10320784 2003-05-09
DE10336183 2003-08-07
DE102004004142A DE102004004142A1 (de) 2003-05-09 2004-01-28 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine

Publications (1)

Publication Number Publication Date
MY148252A true MY148252A (en) 2013-03-29

Family

ID=33420016

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20041687A MY148252A (en) 2003-05-09 2004-05-07 6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines

Country Status (9)

Country Link
EP (1) EP2298773B1 (enExample)
JP (1) JP5277303B2 (enExample)
CL (1) CL2004000978A1 (enExample)
DE (1) DE102004004142A1 (enExample)
MY (1) MY148252A (enExample)
NZ (1) NZ543812A (enExample)
PE (1) PE20050201A1 (enExample)
RU (1) RU2383546C2 (enExample)
TW (1) TWI350836B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2904820C (en) * 2013-04-05 2021-05-18 Eisai R&D Management Co., Ltd. Pyridinylpyrazoloquinoline compound
SG11201909359YA (en) 2017-06-01 2019-11-28 Eisai R&D Man Co Ltd Pharmaceutical composition comprising pde9 inhibitor
WO2018221550A1 (ja) 2017-06-01 2018-12-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピラゾロキノリン誘導体とメマンチンの併用による認知症治療剤
JP7269875B2 (ja) 2017-06-01 2023-05-09 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピラゾロキノリン誘導体を含有するレビー小体病治療剤
RU2019135834A (ru) 2017-06-01 2021-07-13 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Терапевтическое средство для лечения деменции, представляющее собой комбинацию производного пиразолохинолина и донепезила

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH396927A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
DE1147234B (de) 1960-05-11 1963-04-18 Ciba Geigy Verfahren zur Herstellung von 1-Isopropyl-4-hydroxy-6-benzyl-pyrazolo[3, 4-d]pyrimidin
DE1161281B (de) 1960-05-11 1964-01-16 Ciba Aktiengesellschaft, Basel (Schweiz) Verfahren zur Herstellung von 1-Alkyl-6-aralkyl-pyrazoloÄ3,4-dÜ-pyrimidinen.
CH396925A (de) * 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
DE1149013B (de) 1960-05-11 1963-05-22 Ciba Geigy Verfahren zur Herstellung von 4-Oxo-4, 5-dihydro-pyrazolo-[3, 4-d]Pyrimidinen
CH396924A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung von 4-Mercapto-pyrazolo(3,4-d)pyrimidinen
CH396926A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
US3732225A (en) 1970-07-23 1973-05-08 Squibb & Sons Inc Pyrazolo(3,4-d)pyrimidine derivatives
US3847908A (en) 1973-03-05 1974-11-12 Squibb & Sons Inc 6-styrylpyrazolo(3,4-d)pyrimidinones and pyrimidines
DE59009485D1 (de) 1989-01-26 1995-09-14 Bayer Ag Optisch aktive (Meth)Acrylsäure-Derivate, ihre Herstellung, ihre Polymerisation zu optisch aktiven Polymeren und deren Verwendung.
RU2104216C1 (ru) * 1994-01-10 1998-02-10 Акционерное общество открытого типа "Таганрогский авиационный научно-технический комплекс им.Г.М.Бериева" Замок
DE19709877A1 (de) 1997-03-11 1998-09-17 Bayer Ag 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
WO2002009713A2 (de) * 2000-08-01 2002-02-07 Bayer Aktiengesellschaft Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung
HN2002000317A (es) * 2001-11-02 2003-05-21 Pfizer Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
PL370599A1 (en) * 2001-11-02 2005-05-30 Pfizer Products Inc. Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
DE10219435A1 (de) * 2002-05-02 2003-11-13 Bayer Cropscience Ag Substituierte Pyrazolo-pyrimidin-4-one

Also Published As

Publication number Publication date
PE20050201A1 (es) 2005-05-27
DE102004004142A1 (de) 2004-11-25
TWI350836B (en) 2011-10-21
RU2383546C2 (ru) 2010-03-10
CL2004000978A1 (es) 2005-03-18
JP5277303B2 (ja) 2013-08-28
TW200508237A (en) 2005-03-01
RU2005138339A (ru) 2006-08-10
JP2012036221A (ja) 2012-02-23
EP2298773B1 (de) 2013-06-19
NZ543812A (en) 2010-06-25
EP2298773A1 (de) 2011-03-23

Similar Documents

Publication Publication Date Title
WO2003055878A8 (de) 2-heteroarylcarbonsäureamide
WO2003078431A8 (de) Aza- bicyclische n-biarylamide mit affinität zum alpha7 nikotinischen acetylcholin-rezeptor
EP1432714A4 (en) CHEMICAL COMPOUNDS
IL173204A0 (en) Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments
TW200738270A (en) Method of treating depression using a TNFα antibody
TW200505875A (en) Novel compounds
PL378065A1 (pl) Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych
IL189914A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
WO2004026286A3 (de) Selektive phosphodiesterase 9a-inhibitoren als arzneimittel zur verbesserung kognitiver prozesse
MX272108B (es) Heterociclos sustituidos.
DE50305587D1 (en) 2-heteroarylcarbonsäureamide
MX2007002470A (es) Fenilaminotiazoles sustituidos y su uso.
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
WO2007000325A3 (de) Substituierte 1-oxa-3,8-diazaspiro[4.5]-decan-2-on-verbindungen und deren verwendung zur herstellung von arzneimitteln
WO2004043379A3 (en) Chemical compounds
TW200510449A (en) Acylated nonadepsipeptides
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
TW200517144A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
WO2005010165A3 (en) Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.
TW200621799A (en) Acylated nonadepsipeptides II
AU2003262026A1 (en) Method of producing structural body that functions as seat, backrest, partition, etc., and structural body produced by the method
MY148252A (en) 6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines
SE0300457D0 (sv) Novel compounds